We are live on ! Find out more
HKAM

Horizon Kinetics Asset Management Portfolio holdings

AUM $9.23B
1-Year Est. Return 27.52%
This Fund
S&P 500
This Quarter Est. Return
-10.74%
1 Year Est. Return
+27.52%
3 Year Est. Return
+184.83%
5 Year Est. Return
+256.84%
10 Year Est. Return
AUM
$5.21B
AUM Growth
-$852M
Cap. Flow
-$95.3M
Cap. Flow %
-1.83%
Top 10 Hldgs %
68.97%
Holding
354
New
30
Increased
78
Reduced
145
Closed
20

Sector Composition

Rank Sector Weight
1 Energy 53.96%
2 Materials 10.74%
3 Financials 8.73%
4 Consumer Discretionary 4.06%
5 Technology 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGT icon
301
BlackRock Floating Rate Income Trust
BGT
$326M
$142K ﹤0.01%
12,678
PML
302
PIMCO Municipal Income Fund II
PML
$491M
$141K ﹤0.01%
15,050
PACB icon
303
Pacific Biosciences
PACB
$363M
$139K ﹤0.01%
12,000
LILAK icon
304
Liberty Latin America Class C
LILAK
$1.64B
$139K ﹤0.01%
18,465
-72
-0.4% -$573
EVV
305
Eaton Vance Limited Duration Income Fund
EVV
$1.08B
$123K ﹤0.01%
12,456
BLUE
306
DELISTED
bluebird bio
BLUE
$121K ﹤0.01%
+1,900
New +$217K
HLN icon
307
Haleon
HLN
$43.2B
$119K ﹤0.01%
14,673
-1,300
-8% -$10.4K
GALT icon
308
Galectin Therapeutics
GALT
$324M
$118K ﹤0.01%
56,000
+30,000
+115% +$48.4K
EVF
309
Eaton Vance Senior Income Trust
EVF
$91M
$116K ﹤0.01%
21,730
VCSH icon
310
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$114K ﹤0.01%
1,498
-21,700
-94% -$1.64M
NMZ icon
311
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.22B
$112K ﹤0.01%
10,369
-274
-3% -$2.9K
KYN icon
312
Kayne Anderson Energy Infrastructure Fund
KYN
$2.42B
$110K ﹤0.01%
12,701
-1,060
-8% -$9.29K
VTN icon
313
Invesco Trust for Investment Grade New York Municipals
VTN
$168M
$109K ﹤0.01%
+10,414
New +$108K
JPS
314
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$107K ﹤0.01%
16,601
NUV icon
315
Nuveen Municipal Value Fund
NUV
$1.91B
$102K ﹤0.01%
11,632
ALLO icon
316
Allogene Therapeutics
ALLO
$711M
$98.8K ﹤0.01%
+20,000
New +$128K
OIS icon
317
Oil States International
OIS
$518M
$95K ﹤0.01%
+11,410
New +$96.7K
DCOY
318
Decoy Therapeutics
DCOY
$2.1M
$61.9K ﹤0.01%
+23
New +$74K
VMEO
319
DELISTED
Vimeo
VMEO
$48.6K ﹤0.01%
12,688
-223
-2% -$875
VVR icon
320
Invesco Senior Income Trust
VVR
$456M
$36.8K ﹤0.01%
10,000
APLD icon
321
Applied Digital
APLD
$8.7B
$32.4K ﹤0.01%
14,470
+2,894
+25% +$7.22K
TTI icon
322
TETRA Technologies
TTI
$1.28B
$28.8K ﹤0.01%
+10,880
New +$37.9K
TCRT icon
323
Alaunos Therapeutics
TCRT
$4.79M
$21.4K ﹤0.01%
227
NCNA
324
NuCana
NCNA
$6.24M
$18.7K ﹤0.01%
4
KEEL
325
Keel Infrastructure Corp
KEEL
$2.16B
$17.8K ﹤0.01%
18,300

Similar funds

Horizon Kinetics Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Horizon Kinetics Asset Management held 354 positions worth $5.21B, down 14% from $6.06B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Horizon Kinetics Asset Management's Q1 2023 filing shows 30 new, 78 increased, 145 reduced and 20 closed positions. Its largest new stake was Horizon Kinetics SPAC Active ETF: 83,059 shares worth $7.97M. The largest sale was Weyerhaeuser, an estimated $27.6M.

By sector, the portfolio is most concentrated in Energy at 54% of assets, down from 62% a quarter earlier, followed by Materials and Financials.

  • Horizon Kinetics Asset Management's largest Q1 2023 buy was Horizon Kinetics SPAC Active ETF: 83,059 shares worth $7.97M.
  • Horizon Kinetics Asset Management added most to Vanguard Ultra-Short Bond ETF in Q1 2023, an estimated $9.59M increase.
  • Horizon Kinetics Asset Management's biggest Q1 2023 reduction was Weyerhaeuser, cutting an estimated $27.6M.
  • Horizon Kinetics Asset Management fully exited GAMCO Investors, Inc. in Q1 2023, selling an estimated $6.96M.
  • Horizon Kinetics Asset Management's ten largest holdings make up 69% of its $5.21B portfolio in Q1 2023.
  • Horizon Kinetics Asset Management opened 30 new positions and closed 20 in Q1 2023.
  • Horizon Kinetics Asset Management's portfolio value fell 14% quarter-over-quarter to $5.21B.

Based on Horizon Kinetics Asset Management's 13F filing for Q1 2023, filed 12 May 2023.